ERIK FRIEDLY: Open Payments
NPI 1861018947 · SPRINGDALE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 18 payments from 11 companies in 2025. Trend: 2023 $40 · 2024 $299 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| PharmaEssentia USA Corporation | 1 | $121 |
| Iovance Biotherapeutics, Inc. | 4 | $54 |
| Daiichi Sankyo Inc. | 3 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $31 |
| JAZZ PHARMACEUTICALS INC. | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Aveo Pharmaceuticals, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| SOBI, INC | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
Products named: BESREMI, Amtagvi, Enhertu, KISQALI, HYQVIA, FOTIVDA, TIVDAK, Doptelet.
Industry payments across AR — which companies pay providers there.
